Sign in
4

Changes in Ownership

DiaMedica Therapeutics Inc. Filed Acc 0001235802-23-000061

Options or other derivatives

  • President and CEO acquired 181,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pauls Dietrich John President and CEO 2023-06-01 Grant or award · Stock option (right to buy) +181,000 181,000 D
Loading xslF345X04/primary_doc.xml…